Julie Rubinstein is President of Adaptive Biotechnologies Corp. Currently has a direct ownership of 472,754 shares of ADPT, which is worth approximately $2.21 Million. The most recent transaction as insider was on Dec 21, 2020, when has been sold 15,000 shares (Common Stock) at a price of $59.44 per share, resulting in proceeds of $891,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K
0% 3M change
40.36% 12M change
Total Value Held $2.21 Million

JULIE RUBINSTEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2020
SELL
Open market or private sale
$891,600 $59.44 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Oct 01 2020
SELL
Open market or private sale
$721,525 $49.0 p/Share
14,725 Reduced 100.0%
0 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$12,369 $0.84 p/Share
14,725 Added 50.0%
14,725 Common Stock
Sep 29 2020
SELL
Open market or private sale
$3,920,000 $49.0 p/Share
80,000 Reduced 100.0%
0 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$67,200 $0.84 p/Share
80,000 Added 50.0%
80,000 Common Stock
JR

Julie Rubinstein

President
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT